NovaBridge Biosciences Payments to Acquire Investments
NovaBridge Biosciences (NBP) reported Payments to Acquire Investments of CNY 885.58 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2024-04-30
CNY
| Period end | Payments to Acquire Investments 6 month | Payments to Acquire Investments 12 month |
|---|---|---|
| 2023-12-31 | 885.58M CNY 20-F · filed 2024-04-30 | |
| 2022-12-31 | 7.41B CNY 20-F · filed 2024-04-30 | |
| 2022-06-30 | 1.81B CNY 6-K · filed 2022-11-10 | |
| 2021-12-31 | 10.17B CNY 20-F · filed 2024-04-30 | |
| 2021-06-30 | 4.05B CNY 6-K · filed 2022-11-10 | |
| 2020-12-31 | 2.49B CNY 20-F · filed 2023-05-01 |
USD
| Period end | Payments to Acquire Investments 6 month | Payments to Acquire Investments 12 month |
|---|---|---|
| 2023-12-31 | $124.73M 20-F · filed 2024-04-30 | |
| 2022-12-31 | $1.07B 20-F · filed 2023-05-01 | |
| 2022-06-30 | $269.93M 6-K · filed 2022-11-10 |